Over the last 10 years, there have been great advances in knowledge concern
ing changes in tissue perfusion and its prognostic implications. Has this t
ranslated into improved patient management:, We review the clinical trials
that have deliberately increased tissue oxygen delivery by increasing cardi
ac output. We have divided the studies into those that intervene early or t
hose that intervene late in the course of a patient's illness. Although the
re are methodological problems limiting interpretation of the results, we s
how a combined odds ratio of a reduction in mortality for the early studies
but not for the late studies. We conclude that a treatment policy whereby
oxygen delivery is deliberately increased improves patient outcome if it is
initiated early, prior to the onset of organ failure.